NRX Pharmaceuticals (NASDAQ:NRXP) just reported results for the second quarter of 2024.
- NRX Pharmaceuticals reported earnings per share of -75 cents. This was below the analyst estimate for EPS of -58 cents.
- The company did not report any revenue for the quarter.